Oricula Therapeutics

0 followers

‌

Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.

Industries

Pharmaceutical

Headquarters

Seattle, United States

Employees

1-10

Links

Org chart

Vince Groppi

Chief Executive Officer

Vince Groppi

Collapse

Graham Johnson

NuPharmAdvise, President

Marc Bailie

Chief Development Officer, INDS

David W. Raible

University of Washington, Professor

Teams

Leadership Team

5 members

Offices

Similar companies

Bristol-Myers Squibb

205 followers

Walgreens Boots Alliance

109 followers

NYU Langone Health

14 followers

AbbVie

195 followers

Cambrex

3 followers

Corcept Therapeutics

2 followers

Frontage Laboratories, Inc

1 follower

University of Georgia

11 followers

DM Clinical Research

14 followers

Sonic

3 followers

AstraZeneca

320 followers

Explore companies

��������